Abstract:Background: Retinal vein occlusion (RVO) is a major cause of vision impairment globally. Obstruction in the retinal venous system is often due to thrombus formation at arteriovenous crossing points, leading to symptoms localized to the affected retinal area. Systemic conditions like hypertension, diabetes mellitus, dyslipidemia and heart disease are recognized risk factors for RVO, influencing the components of Virchow's triad. Objective: This work aims to provide an updated overview of systemic risk factors associated with branch retinal vein occlusion (BRVO) development and to explore management options for the prevention or modification of associated risks. Methods: Review of the literature concerning the pathogenesis and risk factors of BRVO, including diabetes mellitus, hyperlipidemia, hematologic conditions, hormonal factors, thyroid disease, and the impact of COVID-19 and related vaccines on BRVO incidence. Results: Diabetes mellitus contributes to BRVO through mechanisms like endothelial dysfunction and thrombogenesis. Hyperlipidemia - through lipid-mediated vascular changes - and hematologic conditions - by predisposing to hypercoagulability - significantly increase BRVO risk. Hormonal imbalances and thyroid diseases also influence BRVO development through their effects on vascular and hemostatic systems. Furthermore, COVID-19 has been identified as a potential risk factor for BRVO, possibly due to its pro- thrombotic effects. Conclusion: Branch retinal vein occlusion represents a complex interplay of systemic and local vascular factors, necessitating comprehensive management strategies. Early detection and modification of risk factors is crucial for preventing vision impairment associated with BRVO. The ongoing pandemic and its systemic implications underscore the importance of continued review into the multifactorial etiology of BRVO and optimization of management strategies to improve patient outcomes.

Central Retinal Vein Occlusion in a 28-Year-Old Female Patient: A Case Report

Use of Recombinant Human Erythropoietin and Risk of Severe Retinopathy in Extremely Low‐Birth‐Weight Infants

Simultaneous Branch Retinal Artery and Central Retinal Vein Occlusion Improved with No Ocular Therapy: A Case Report

Comparison of Azithromycin and Doxycycline in the Treatment of Erythema migrans

Systemic Risk Factors in Branch Retinal Vein Occlusion: a Comprehensive Review

Risk Factors for Developing Neovascular Glaucoma in Central Retinal Vein Occlusion: Two-Year Real-World Study

Risk Factors for Branch and Central Retinal Vein Occlusion

Branch Retinal Vein Occlusion in a COVID-19 Positive Patient

Risks and Management of Central Serous Chorioretinopathy in a Middle-Aged Female

Central Retinal Artery Occlusion in Young Adults at High Altitude: Thin Air, High Stakes

Clinical assessment of relationship between the choroidal and retinal hemodynamic in young women with retinal vein occlusion

Hemi-retinal vein occlusion: Characterizing a rare retinal vasculopathy

Health information exchange among U.S. hospitals: who's in, who's out, and why?

Characterization of giant perivascular spaces in the thymus of the nonobese diabetic mouse.

Central retinal vein occlusion in patients with metastatic solid tumors on tyrosine kinase inhibitors: a report of case series and literature review

Poland syndrome coexisting with blaschkolinear congenital melanocytic nevi.

Time to initiate anti-vascular endothelial growth factor therapy and visual outcome in central retinal vein occlusion

Central retinal artery and Common Carotid artery occlusions following COVID-19 infection: A case report

The Choroidal Vascularity Indices of Treatment-Naïve Patients with Central Retinal Vein Occlusion and Age-/Sex-Matched Controls

Central Retinal Artery Occlusion With Cilioretinal Artery Sparing

Central corneal thickness, axial length, anterior chamber and optic disc structure in patients with central and branch retinal vein occlusion